| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |